Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells.
暂无分享,去创建一个
[1] A. Hume,et al. Turmeric/curcumin , 2019, Pharmacy Today.
[2] Chenchen Wang,et al. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. , 2018, Seminars in arthritis and rheumatism.
[3] S. Atkin,et al. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway , 2018, Journal of cellular physiology.
[4] H. Rittner,et al. Role of curcumin in the management of pathological pain. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[5] R. Raffa,et al. Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesia , 2018, Journal of clinical pharmacy and therapeutics.
[6] M. Amri,et al. The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia , 2018, Journal of Neuroimmunology.
[7] M. Caplin,et al. Pollution and respiratory disease: can diet or supplements help? A review , 2018, Respiratory Research.
[8] S. Franks,et al. Efficacy of curcumin for age-associated cognitive decline: a narrative review of preclinical and clinical studies , 2018, GeroScience.
[9] H. Abrahamse,et al. Therapeutic Potential and Recent Advances of Curcumin in the Treatment of Aging-Associated Diseases , 2018, Molecules.
[10] Xi Zheng,et al. Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease , 2018, Neural regeneration research.
[11] I. Boileau,et al. A systematic review of the role of the nociceptin receptor system in stress, cognition, and reward: relevance to schizophrenia , 2018, Translational Psychiatry.
[12] Eva Budinska,et al. A critical comparison of topology-based pathway analysis methods , 2018, PloS one.
[13] N. Mkrtchyan,et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study , 2018, BMC Complementary and Alternative Medicine.
[14] M. Mbiantcha,et al. Antinociceptive Activities of the Methanolic Extract of the Stem Bark of Boswellia dalzielii Hutch. (Burseraceae) in Rats Are NO/cGMP/ATP-Sensitive-K+ Channel Activation Dependent , 2017, Evidence-based complementary and alternative medicine : eCAM.
[15] A. Riva,et al. A novel boswellic acids delivery form (Casperome®) in the management of musculoskeletal disorders: a review. , 2017, European review for medical and pharmacological sciences.
[16] Adriaan W. Bruijnzeel. Neuropeptide systems and new treatments for nicotine addiction , 2016, Psychopharmacology.
[17] T. Efferth,et al. Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance , 2016, Scientific Reports.
[18] G. Belcaro,et al. A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players. , 2016, European review for medical and pharmacological sciences.
[19] A. Zimmer,et al. Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain , 2016, Scientific Reports.
[20] Alex Gutteridge,et al. Interpreting transcriptional changes using causal graphs: new methods and their practical utility on public networks , 2016, BMC Bioinformatics.
[21] M. Bruchas,et al. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems , 2016, Pharmacological Reviews.
[22] N. Zaveri. Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility. , 2016, Journal of medicinal chemistry.
[23] R. Andero. Nociceptin and the nociceptin receptor in learning and memory , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[24] Lin Xu,et al. Advances in understanding cartilage remodeling , 2015, F1000Research.
[25] J. Tajti,et al. Migraine and neuropeptides , 2015, Neuropeptides.
[26] Yong-Jing Gao,et al. Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis , 2015, Scientific Reports.
[27] G. Merolla,et al. Co-analgesic therapy for arthroscopic supraspinatus tendon repair pain using a dietary supplement containing Boswelliaserrata and Curcumalonga: a prospective randomized placebo-controlled study , 2015, MUSCULOSKELETAL SURGERY.
[28] S. Karimian,et al. Attenuation of Morphine Withdrawal Syndrome by Various Dosages of Curcumin in Comparison with Clonidine in Mouse: Possible Mechanism , 2015, Iranian journal of medical sciences.
[29] Y. Liu,et al. Curcumin Attenuates Opioid Tolerance and Dependence by Inhibiting Ca2+/Calmodulin-Dependent Protein Kinase II α Activity , 2015, The Journal of Pharmacology and Experimental Therapeutics.
[30] B. Aggarwal,et al. The Multifaceted Role of Curcumin in Cancer Prevention and Treatment , 2015, Molecules.
[31] L. Devi,et al. Challenges for opioid receptor nomenclature: IUPHAR Review 9 , 2015, British journal of pharmacology.
[32] M. Tazir,et al. IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. , 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[33] P. U. Rani,et al. A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model , 2014, Indian journal of pharmacology.
[34] Qing Zhu,et al. Antinociceptive effects of curcumin in a rat model of postoperative pain , 2014, Scientific Reports.
[35] J. Pintar,et al. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. , 2014, Pharmacology & therapeutics.
[36] Alfonso Valencia,et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia , 2014, Genome research.
[37] H. Banafshe,et al. Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. , 2014, European journal of pharmacology.
[38] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[39] R. Stephens,et al. An introduction to pain pathways and mechanisms. , 2013, British journal of hospital medicine.
[40] Ying Liu,et al. Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles. , 2013, Molecular pharmaceutics.
[41] J. Montaner,et al. ADAMTS proteoglycanases in the physiological and pathological central nervous system , 2013, Journal of Neuroinflammation.
[42] T. Shin,et al. Antinociceptive curcuminoid, KMS4034, effects on inflammatory and neuropathic pain likely via modulating TRPV1 in mice. , 2013, British journal of anaesthesia.
[43] B. Aggarwal,et al. Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers , 2013, British journal of pharmacology.
[44] D. Lambert,et al. Opioids and immune modulation: more questions than answers. , 2013, British journal of anaesthesia.
[45] Feng-tao Ji,et al. Curcumin exerts antinociceptive effects by inhibiting the activation of astrocytes in spinal dorsal horn and the intracellular extracellular signal-regulated kinase signaling pathway in rat model of chronic constriction injury. , 2013, Chinese medical journal.
[46] J. Fichna,et al. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives , 2013, Journal of Gastroenterology.
[47] G. Castañeda-Hernández,et al. Evidence for the Participation of ATP-sensitive Potassium Channels in the Antinociceptive Effect of Curcumin , 2012, The Korean journal of pain.
[48] Ahmed Enayetallah,et al. Causal reasoning on biological networks: interpreting transcriptional changes , 2012, Bioinform..
[49] B. Aggarwal,et al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities , 2012, Clinical and experimental pharmacology & physiology.
[50] Zhi-Li Huang,et al. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: Descending monoamine system and opioid receptors are differentially involved , 2012, Neuropharmacology.
[51] Seongheon Lee,et al. Analgesic Effects of Intrathecal Curcumin in the Rat Formalin Test , 2012, The Korean journal of pain.
[52] R. Al-Hasani,et al. Molecular mechanisms of opioid receptor-dependent signaling and behavior. , 2011, Anesthesiology.
[53] Krishna Dalal,et al. ADAMTS‐4 and ADAMTS‐5: Key enzymes in osteoarthritis , 2011, Journal of cellular biochemistry.
[54] P. Romão,et al. NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases , 2011, Journal of amino acids.
[55] W. Armstead. Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease. , 2011, Cardiovascular therapeutics.
[56] F. Weiss,et al. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin , 2010, Brain Research.
[57] K. Dawe,et al. Endogenous Nociceptin / Orphanin FQ System Involvement in Hypothalamic-Pituitary-Adrenal Axis Responses: Relevance to Models of Inflammation , 2009, Journal of neuroendocrinology.
[58] Annarita D'Addabbo,et al. Comparative study of gene set enrichment methods , 2009, BMC Bioinformatics.
[59] H. Ueda,et al. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation , 2009, Neuroreport.
[60] David G. Lambert,et al. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential , 2008, Nature Reviews Drug Discovery.
[61] B. Williams,et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.
[62] E. Tamaddonfard,et al. The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats. , 2008, Pakistan journal of biological sciences : PJBS.
[63] E. Tamaddonfard,et al. Interaction between curcumin and opioid system in the formalin test of rats. , 2007, Pakistan journal of biological sciences : PJBS.
[64] S. Chrubasik,et al. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain , 2007, Phytotherapy research : PTR.
[65] J. Brooks,et al. REVIEW: From nociception to pain perception: imaging the spinal and supraspinal pathways , 2005, Journal of anatomy.
[66] Y. Wong,et al. The ORL1 Receptor: Molecular Pharmacology and Signalling Mechanisms , 2002, Neurosignals.
[67] Takao Ito,et al. Pharmacological profiles of a novel opioid receptor‐like1 (ORL1) receptor antagonist, JTC‐801 , 2002, British journal of pharmacology.
[68] T. Nabeshima,et al. The role of nociceptin in cognition , 1999, Brain Research.
[69] H. Loh,et al. Regulation of opioid receptor activities. , 1999, The Journal of pharmacology and experimental therapeutics.
[70] Marc Parmentier,et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.
[71] H. Ding,et al. Central N/OFQ-NOP Receptor System in Pain Modulation. , 2016, Advances in pharmacology.
[72] N. Zaveri,et al. The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction. , 2016, Progress in molecular biology and translational science.
[73] J. Clark,et al. Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice. , 2013, The journal of pain : official journal of the American Pain Society.
[74] D. Lambert,et al. Nociceptin/orphanin FQ in inflammation and sepsis. , 2011, British journal of anaesthesia.
[75] J. Bondeson,et al. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. , 2008, Clinical and experimental rheumatology.